Category Archives: Cosmetic/aesthetic

Clinical applications of tissue engineering and cell therapy

The market for tissue engineering and cell therapy products is set to grow to nearly $32 billion by 2018. This figure includes bioengineered products that are themselves cells or are actively stimulating cell growth or regeneration, products that often represent a combination of biotechnology, medical device and pharmaceutical technologies. The largest segment in the overall [...]

Ablation Technologies Competing for Growing Patient Volume and Penetration of Clinical Practice, According to New MedMarket Diligence Report

Ablation technologies are a growth medtech field driven as much by physicians pursuing larger caseload as manufacturers developing innovative technologies, according to a new global report from MedMarket Diligence. (PressMethod) – Surgical procedures focus on a wide range of clinical endpoints — the creation of a lesion to block aberrant cardiac rhythms, the destruction of [...]

Clinical applications of ablative technologies market

The largest application for energy-based ablation devices is in cancer therapy, primarily using the radiation therapy modality. Following that is general surgery with its use of electrocautery and electrosurgical devices, RF ablation, cryotherapy, etc. Cardiovascular is thought to be third, even though cardiovascular is making the most noise in the medical press with RF and [...]

Energy modalities and clinical applications in ablation technology

Technologies that destroy tissue for therapeutic benefit are collectively known as ablation technologies.  By a wide range of energy types or other mechanical methods, they are used to destroy, excise or otherwise treat tissue for therapeutic benefit, from the radiation of cancer, the destruction of the endometrial lining of the uterus causing endometriosis, the creation [...]

Clinical applications of ablative technologies

The applications of energy-based technologies for the ablative treatment of tissue are numerous and diverse as a result of the effectiveness of these technologies — which vary widely by energy type (electrosurgery, radiosurgery, gamma knife, brachytherapy, cryogenic therapy, fluidjet/hydrotherapy, microwave ablation, radiofrequency ablation, laser, thermal ablation, and ultrasonic ablation) — and their integration into routine [...]

Ablation Technologies Market to Reach $10 Billion in 2010, According to a New MedMarket Diligence Report

PRLog (Press Release) – Jun 09, 2010 – The practice of surgery has long employed energy-based technologies to excise, cut, ablate, cauterize, destroy or otherwise manipulate tissue to produce therapeutic results. Various energy modalities — from cryotherapy to microwave to radiofrequency to ultrasound to radiation and others — have proven their ability to effect healthy or diseased tissue [...]

Ablation technologies penetrating virtually all clinical specialties

Energy-based ablation devices are powered by a wide variety of sources, resulting in a plethora of devices. These include electrical, radiation, light, radiofrequency, ultrasound, cryotherapy, thermal, microwave and hydromechanical. This array of technology enables the physician, with the appropriate device in hand, to pinpoint and destroy almost any kind of tissue, almost anywhere in the [...]

Clinical applications of medical/surgical sealants and glues

  The applications of surgical sealants, glues and wound closure are many and are rapidly multiplying as more credible data is generated on each application and as physicians gain comfort in working with the products in routine clinical practice. Below is a sample of surgical sealants, glues and wound closure applications by clinical area: Source: [...]

Technology migration in medtech markets

Western markets, including the U.S. and Europe, tend to drive the formation of new medical technology markets, which then evolve and migrate to Asia/Pacific and the rest of the world.  While this is not always the case (a notable exception is the technology and market development of fibrin and other blood-based tissue sealants technologies, which [...]

Regenerative medicine promises realized

The first annual Translational Regenerative Medicine Forum that was held April 6-10, 2010, and sponsored by the Regenerative Medicine Foundation highlighted the future promise and needs in this field encompassing succinctly: replacement tissues and organs cell therapies to restore function Other issues addressed include the perennial discussion of policy, funding and the challenges of stem [...]